About Cellavision
Cellavision is a company based in Lund (Sweden) founded in 1994. The company has 236 employees as of December 31, 2024. Cellavision has completed 1 acquisition, including RAL Diagnostics. Cellavision offers products and services including CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents. Cellavision operates in a competitive market with competitors including Diatron, MicroX Labs, LabNow, Livo and Drew Scientific, among others.
- Headquarter Lund, Sweden
- Employees 236 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cellavision Ab
-
Annual Revenue
$65.57 M (USD)6.78as on Dec 31, 2024
-
Net Profit
$12.76 M (USD)7.99as on Dec 31, 2024
-
EBITDA
$19.83 M (USD)5.74as on Dec 31, 2024
-
Latest Funding Round
$12.47 M (USD), Debt – Conventional
Sep 16, 2019
- Investors
-
Employee Count
236
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Cellavision
Cellavision is a publicly listed company on the OMXSTO with ticker symbol CEVI in Sweden, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Cellavision
Cellavision offers a comprehensive portfolio of products and services, including CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents.
Device for automated digital microscopy of blood samples
Tools for remote review and analysis of lab samples
Reagents for hematology testing and sample preparation
People of Cellavision
Unlock access to complete
Unlock access to complete
Funding Insights of Cellavision
- Total Funding Total Funding
- Total Rounds 1
- Last Round Debt – Conventional — $12.5M
-
First Round
First Round
(16 Sep 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2019 | Amount | Debt – Conventional - Cellavision | Valuation |
investors |
Investors in Cellavision
Investments & Acquisitions by Cellavision
Cellavision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include RAL Diagnostics.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Stains & Instruments for microscopy
|
1916 |
Financial Statements - Cellavision
Cellavision Comparisons
Competitors of Cellavision
Cellavision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diatron, MicroX Labs, LabNow, Livo and Drew Scientific, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hematology and clinical chemistry analyzers with reagents are manufactured.
|
|
| domain | founded_year | HQ Location |
MEMS-based biochips are developed for blood cell counting.
|
|
| domain | founded_year | HQ Location |
Offers WBC counting point-of-care diagnostic systems for healthcare needs.
|
|
| domain | founded_year | HQ Location |
Next-generation pathology laboratory equipment is manufactured and supplied.
|
|
| domain | founded_year | HQ Location |
Analytical Instruments for Clinical and Veterinary Hematology and HbA1c
|
Frequently Asked Questions about Cellavision
Cellavision was founded in 1994 and raised its 1st funding round 25 years after it was founded.
Cellavision is headquartered in Lund, Sweden.
As of Dec 31, 2024, the latest employee count at Cellavision is 236.
Annual revenue of Cellavision is $65.57M as on Dec 31, 2024.
Cellavision develops and markets solutions for digital microscopy. Its proprietary platforms improve manual microscopy through automatic analyzers that use a combination if digital imaging, artificial intelligence and IT support. The company specializes in hematology and has analytic solutions for the differential diagnoses for peripheral blood smears, advanced RBC analyses and other body fluid smears.
Cellavision's top competitors include MicroX Labs, Diatron and Livo.
Cellavision offers CellaVision® DM9600, CellaVision® Software, and CellaVision® Reagents.
Yes, Cellavision is publicly traded on OMXSTO under the ticker symbol CEVI.
Cellavision has made 1 acquisition, including RAL Diagnostics.
Cellavision has 1 investor. Key investors include SEB.
The ticker symbol of Cellavision is CEVI on OMXSTO.